The only report on CSPG4-directed targeting of leukemia cell was predicated on the anti-CSPG4 225.28 antibody, the therapeutic efficacy of which against 11q23-rearranged leukemia cells was evaluated in a xenograft mouse model [34]. This evidence concerns the gene CSPG4 and leukemia.